Guided Therapeutics Inc Stock OTC Bulletin Board
Equities
US40171F2048
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | 13K 17.78K | Sales 2023 | 98K 134K | Capitalization | 8.31M 11.36M |
---|---|---|---|---|---|
Net income 2022 | -4M -5.47M | Net income 2023 | -3M -4.1M | EV / Sales 2022 | 1,118 x |
Net cash position 2022 | 50K 68.38K | Net Debt 2023 | 1.47M 2.01M | EV / Sales 2023 | 99.7 x |
P/E ratio 2022 |
-1.96
x | P/E ratio 2023 |
-2.09
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.2% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 68 | 92-10-26 |
Founder | 68 | 92-10-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Imhoff
BRD | Director/Board Member | 74 | 06-04-09 |
Richard Blumberg
BRD | Director/Board Member | 67 | 16-11-09 |
Mark Faupel
CEO | Chief Executive Officer | 68 | 92-10-26 |
1st Jan change | Capi. | |
---|---|---|
+11.22% | 226B | |
+9.26% | 188B | |
+13.13% | 137B | |
+25.89% | 108B | |
+0.34% | 63.19B | |
+11.53% | 52.26B | |
+5.62% | 51B | |
+6.24% | 43.89B | |
+4.72% | 38.07B |